StonvexLoading…
StonvexStonvexStonvexCore line items from NCNO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $594.78M | $445.12M | $292.95M | $144.14M |
Operating Income | $3.73M | $907.00K | $-10.81M | $-1.51M |
Net Income | $5.18M | $-3.16M | $-9.70M | $5.56M |
EPS (Diluted) | $0.05 | $-0.03 | $-0.08 | $0.05 |
Total Assets | $1.65B | $1.56B | $1.62B | $1.65B |
Total Liabilities | $579.45M | $507.25M | $548.85M | $570.00M |
Cash & Equivalents | $88.37M | $87.59M | $122.94M | $133.23M |
Free Cash Flow OCF − CapEx | $82.56M | $70.09M | $65.19M | $52.60M |
Shares Outstanding | 113.90M | 114.43M | 115.44M | 115.24M |